Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-11
DOI
10.1186/s13048-019-0596-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1
- (2019) Li-Ya Zhang et al. Cancer Biomarkers
- Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
- (2019) Jerry Harb et al. Current Oncology Reports
- HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3
- (2019) Shanshan Dong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-590-3p Targets Cyclin G2 and FOXO3 to Promote Ovarian Cancer Cell Proliferation, Invasion, and Spheroid Formation
- (2019) Mohamed Salem et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer
- (2019) Zheng Huang et al. Cell Death & Disease
- Activation of Wnt signaling promotes olaparib resistant ovarian cancer
- (2019) Tomomi M. Yamamoto et al. MOLECULAR CARCINOGENESIS
- Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
- (2019) Shreya Raghavan et al. Journal for ImmunoTherapy of Cancer
- A Review of the Role of Wnt in Cancer Immunomodulation
- (2019) Whitney N. Goldsberry et al. Cancers
- A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2019) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Silencing LGR6 Attenuates Stemness and Chemoresistance via Inhibiting Wnt/β-Catenin Signaling in Ovarian Cancer
- (2019) Xiaohong Ruan et al. Molecular Therapy-Oncolytics
- CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis
- (2018) Qian Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis
- (2018) Zhen Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells
- (2018) Dominique Z. Jones et al. BMC CANCER
- miRNA-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-versican pathway
- (2018) Mohamed Salem et al. CANCER RESEARCH
- MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin
- (2018) Yang Liu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- hsa_circ_0000177-miR-638-FZD7-Wnt Signaling Cascade Contributes to the Malignant Behaviors in Glioma
- (2018) Zhiqiang Chen et al. DNA AND CELL BIOLOGY
- Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses
- (2018) Jennifer J. Mueller et al. GYNECOLOGIC ONCOLOGY
- Long non-coding RNAs in ovarian cancer
- (2018) Lei Zhan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface
- (2018) Maggie K. S. Tang et al. Nature Communications
- CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway
- (2018) Minnan Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The circular RNA circ-ITCH suppresses ovarian carcinoma progression through targeting miR-145/RASA1 signaling
- (2018) Jinghui Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Theaflavin-3,3′-digallate inhibits ovarian cancer stem cells via suppressing Wnt/β-Catenin signaling pathway
- (2018) Haibo Pan et al. Journal of Functional Foods
- Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
- (2018) Seema C. Parte et al. Journal of Ovarian Research
- hsa_circ_0061140 Knockdown Reverses FOXM1-Mediated Cell Growth and Metastasis in Ovarian Cancer through miR-370 Sponge Activity
- (2018) Qizhen Chen et al. Molecular Therapy-Nucleic Acids
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Cis-acting circ-CTNNB1 promotes β-catenin signaling and cancer progression via DDX3-mediated transactivation of YY1
- (2018) Feng Yang et al. CANCER RESEARCH
- Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling
- (2018) Geyan Wu et al. CLINICAL CANCER RESEARCH
- MiR‐34c/SOX9 axis regulates the chemoresistance of ovarian cancer cell to cisplatin‐based chemotherapy
- (2018) Songshu Xiao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1
- (2018) Jinlan Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells
- (2018) Qiong Liu et al. GENE
- Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
- (2018) Xiaofei Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer
- (2017) Yuan Cao et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway
- (2017) Chunyan Wei et al. GENE
- TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2
- (2017) Hongying Duan et al. GYNECOLOGIC ONCOLOGY
- miRNAs and ovarian cancer: An overview
- (2017) Bornali Deb et al. JOURNAL OF CELLULAR PHYSIOLOGY
- FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
- (2017) Renata A. Tassi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Wnt/beta-catenin pathway: modulating anticancer immune response
- (2017) Sachin Gopalkrishna Pai et al. Journal of Hematology & Oncology
- β-catenin downregulates Dicer to promote ovarian cancer metastasis
- (2017) S K Y To et al. ONCOGENE
- miR-762 can negatively regulate menin in ovarian cancer
- (2017) Rui Hou et al. OncoTargets and Therapy
- Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
- (2017) Shan Deng et al. Oncotarget
- LGR5 and LGR6 in stem cell biology and ovarian cancer
- (2017) Adam J. Schindler et al. Oncotarget
- Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling
- (2017) Yanhui Lou et al. Oncotarget
- DACT1 Overexpression in type I ovarian cancer inhibits malignant expansion and cis-platinum resistance by modulating canonical Wnt signalling and autophagy
- (2017) Ruo-nan Li et al. Scientific Reports
- Identifying and Characterizing circRNA-Protein Interaction
- (2017) William W Du et al. Theranostics
- Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy
- (2017) Chongyuan Zhang et al. MEDICAL SCIENCE MONITOR
- GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer
- (2017) Jing Sun et al. Cancer Medicine
- KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells
- (2016) Hong Chen et al. Cancer Cell International
- Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway
- (2016) Jun Ou-Yang et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
- (2016) S Bernaudo et al. ONCOGENE
- Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer
- (2016) Eileen E. Parkes et al. ONCOLOGIST
- MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression
- (2016) Bairong Xia et al. TUMOR BIOLOGY
- Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway
- (2016) Rui Hou et al. TUMOR BIOLOGY
- Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway
- (2016) Haiyuan Liu et al. TUMOR BIOLOGY
- Hypermethylated APC in serous carcinoma based on a meta-analysis of ovarian cancer
- (2016) Chunyan Shen et al. Journal of Ovarian Research
- Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer
- (2016) Tasuku Mariya et al. Oncotarget
- Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
- (2016) Mijung Kwon et al. Oncotarget
- WNT7A Regulation by miR-15b in Ovarian Cancer
- (2016) James A. MacLean et al. PLoS One
- MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression
- (2015) Xiong Ying et al. BIOMEDICINE & PHARMACOTHERAPY
- High Expressions of Lgr5 and ALDH1 in Primary Epithelial Ovarian Cancer Correlate with Advanced Tumor Stage and Grade as well as Poor Prognosis of the Patients
- (2015) Yanan Sun et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma
- (2015) Rebecca J. Burkhalter et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Wnt Signaling Antagonist Dapper1 Accelerates Dishevelled2 Degradation via Promoting Its Ubiquitination and Aggregate-induced Autophagy
- (2015) Benyu Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer
- (2015) Karoline B Kuchenbaecker et al. NATURE GENETICS
- JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer
- (2015) L Pangon et al. ONCOGENE
- MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK
- (2015) Dongling Zou et al. TUMOR BIOLOGY
- Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
- (2015) Jing Li et al. TUMOR BIOLOGY
- Screening the Molecular Targets of Ovarian Cancer Based on Bioinformatics Analysis
- (2015) Lei Du et al. TUMORI
- Ubiquitin E3 ligase MARCH7 promotes ovarian tumor growth
- (2015) Jianguo Hu et al. Oncotarget
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Screening the Molecular Targets of Ovarian Cancer Based on Bioinformatics Analysis
- (2015) Lei Du et al. TUMORI JOURNAL
- cir-ITCH Plays an Inhibitory Role in Colorectal Cancer by Regulating the Wnt/β-Catenin Pathway
- (2015) Guanli Huang et al. PLoS One
- Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer
- (2015) David W Chan et al. Oncotarget
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- Tankyrases: Structure, Function and Therapeutic Implications in Cancer
- (2014) Teemu Haikarainen et al. CURRENT PHARMACEUTICAL DESIGN
- The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
- (2014) W. de Lau et al. GENES & DEVELOPMENT
- Ovarian Tumor Ascites CD14+ Cells Suppress Dendritic Cell–activated CD4+ T-cell Responses Through IL-10 Secretion and Indoleamine 2,3-Dioxygenase
- (2014) Hannah E. Goyne et al. JOURNAL OF IMMUNOTHERAPY
- Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
- (2014) Ning Wen et al. Journal of Translational Medicine
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
- (2014) S Condello et al. ONCOGENE
- miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
- (2014) FEI GUO et al. ONCOLOGY REPORTS
- Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
- (2014) Fung Zhao et al. PLoS One
- Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway
- (2014) Huidi Liu et al. Journal of Ovarian Research
- Treatment options in recurrent ovarian cancer: latest evidence and clinical potential
- (2014) Daniela Luvero et al. Therapeutic Advances in Medical Oncology
- Silencing of Twist Expression by RNA Interference Suppresses Epithelial-mesenchymal Transition, Invasion, and Metastasis of Ovarian Cancer
- (2013) Wen-Shuang Wang et al. Asian Pacific Journal of Cancer Prevention
- Prognostic Value of MMP-9 in Ovarian Cancer: A Meta-analysis
- (2013) Li-Na Li et al. Asian Pacific Journal of Cancer Prevention
- Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism
- (2013) Salvatore Condello et al. FASEB JOURNAL
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer stem cells: Are they real and why are they important?
- (2013) Monjri M. Shah et al. GYNECOLOGIC ONCOLOGY
- Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis
- (2013) Mijung Kwon et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of Wnt7a Is Associated With Tumor Progression and Unfavorable Prognosis in Endometrial Cancer
- (2013) Yunduo Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets
- (2013) Nuzhat Ahmed et al. MOLECULAR ASPECTS OF MEDICINE
- TET enzymes, TDG and the dynamics of DNA demethylation
- (2013) Rahul M. Kohli et al. NATURE
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells
- (2013) Caroline E. Ford et al. PLoS One
- Huaier Aqueous Extract Inhibits Ovarian Cancer Cell Motility via the AKT/GSK3β/β-Catenin Pathway
- (2013) Xiaohui Yan et al. PLoS One
- Wnt Stabilization of -Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies
- (2013) S.-E. Kim et al. SCIENCE
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion
- (2012) Xiaoxia Hu et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers
- (2012) Uttara Saran et al. BMC CELL BIOLOGY
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma
- (2012) Jing Zhu et al. CARCINOGENESIS
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Matrix Rigidity Activates Wnt Signaling through Down-regulation of Dickkopf-1 Protein
- (2012) Maria V. Barbolina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/ -Catenin Pathway
- (2012) S. Yoshioka et al. MOLECULAR CANCER RESEARCH
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients
- (2012) Francis Jacob et al. PLoS One
- Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
- (2012) Renyue Bao et al. PLoS One
- Wnt/ -catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled
- (2012) D. V. F. Tauriello et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Secreted and Transmembrane Wnt Inhibitors and Activators
- (2012) C.-M. Cruciat et al. Cold Spring Harbor Perspectives in Biology
- The -Catenin Destruction Complex
- (2012) J. L. Stamos et al. Cold Spring Harbor Perspectives in Biology
- Epithelial–Mesenchymal Transition in Ovarian Carcinoma
- (2012) Ben Davidson et al. Frontiers in Oncology
- Developmental and Pathological Angiogenesis
- (2011) Alicia S. Chung et al. Annual Review of Cell and Developmental Biology
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
- (2011) Nu Zhang et al. CANCER CELL
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- MMP-2 functions as an early response protein in ovarian cancer metastasis
- (2011) Hilary A. Kenny et al. CELL CYCLE
- Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity
- (2011) Hassina Benchabane et al. EMBO JOURNAL
- Y654 of β-catenin is essential for FLT3/ITD-related tyrosine phosphorylation and nuclear localization of β-catenin
- (2011) Tomohiro Kajiguchi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Nodal enhances the activity of FoxO3a and its synergistic interaction with Smads to regulate cyclin G2 transcription in ovarian cancer cells
- (2011) G Fu et al. ONCOGENE
- Identification of a Variable Number of Tandem Repeats Polymorphism and Characterization of LEF-1 Response Elements in the Promoter of the IDO1 Gene
- (2011) Marion Soichot et al. PLoS One
- Emerging links between CDK cell cycle regulators and Wnt signaling
- (2010) Gary Davidson et al. TRENDS IN CELL BIOLOGY
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
- (2009) Tomoko Inaba et al. GYNECOLOGIC ONCOLOGY
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer
- (2009) Samir F. Zohny et al. MEDICAL ONCOLOGY
- Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of -Catenin
- (2009) Y. Cao et al. MOLECULAR AND CELLULAR BIOLOGY
- Dpr Acts as a Molecular Switch, Inhibiting Wnt Signaling when Unphosphorylated, but Promoting Wnt Signaling when Phosphorylated by Casein Kinase Iδ/ε
- (2009) Evelyn Teran et al. PLoS One
- Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
- (2008) Jia Luo CANCER LETTERS
- Cyclin G2 Is Degraded through the Ubiquitin-Proteasome Pathway and Mediates the Antiproliferative Effect of Activin Receptor-like Kinase 7
- (2008) Guoxiong Xu et al. MOLECULAR BIOLOGY OF THE CELL
- Snail promotes Wnt target gene expression and interacts with β-catenin
- (2008) V Stemmer et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started